Distal Lateral Subungual Onychomycosis

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Genesis Therapeutics
Genesis TherapeuticsCA - Burlingame
1 program
Nail Genesis DLSO ProductN/A1 trial
Active Trials
NCT06074315UnknownEst. Jan 2025

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
Genesis TherapeuticsNail Genesis DLSO Product

Clinical Trials (1)

NCT06074315Genesis TherapeuticsNail Genesis DLSO Product

Evaluation of the Effectiveness of Nail Genesis DLSO Product for Onychomycosis

Start: Oct 2023Est. completion: Jan 2025
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space